Mr. Liam Woods:

For clarity, and I am not sure any of these would be a rare disease, but there are conditions that require us to grow our capacity to provide service or to enhance specialism in particular areas. That happens from time to time, which also requires a clinical presence that will take a specialist interest, and investment behind that, to address specific conditions. I am thinking of conditions such as hepatitis C or, as the Deputy mentioned, Lyme disease, where we need to invest in clinical capacity and also consider treatment pathways that were referenced earlier.